CN106177772A - A kind of herbal composite treating bladder cancer and carcinoma of prostate - Google Patents
A kind of herbal composite treating bladder cancer and carcinoma of prostate Download PDFInfo
- Publication number
- CN106177772A CN106177772A CN201610691275.3A CN201610691275A CN106177772A CN 106177772 A CN106177772 A CN 106177772A CN 201610691275 A CN201610691275 A CN 201610691275A CN 106177772 A CN106177772 A CN 106177772A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- rhizoma
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of herbal composite treating bladder cancer and carcinoma of prostate, including following raw material medicaments: Purplevine, Pedicellus et Pericarpium Trapae, Rhizoma Paridis, Rhizoma Arisaematis, Hirudo, crow egg-shaped thing, Bufo siccus Pseudobulbus cremastrae seu pleiones, Scolopendra, Squama Manis, Scorpio, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Semen Coicis, Radix Ginseng Rubra 3, Carapax Trionycis, Thallus Laminariae (Thallus Eckloniae), Sargassum, Aloe, SHANLING, Rhizoma Curcumae, Radix Curcumae, the Radix Astragali, Ganoderma, Herba Solani Lyrati, Radix Clematidis, Radix Salviae Miltiorrhizae, Folium Artemisiae Argyi, Germinatus Phragmitis, Polyporus, Spica Prunellae, Herba Dianthi, Herba Salviae Chinensis, Rhizoma Corydalis, common fig leaf juice part, eupolyphoge sinensis;This medicine has a removing toxic substances and promoting subsidence of swelling pain relieving, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, dampness removing toxin expelling, auxiliary the most eliminating evil, and the effect of enhancing human body immunity function uses the manufacture method of Chinese medicine to make decoction, pill or powder;Early metaphase cancer cure rate 90%, terminal cancer can be survived 5 10 years.
Description
Technical field
The present invention is a kind of herbal composite treating bladder cancer and carcinoma of prostate, belongs to technical field of Chinese medicines.
Background technology
Bladder cancer and carcinoma of prostate are a kind of commonly encountered diseases that current man's sickness rate is higher, due to treatment not in time, often
Its hetero-organization can be transferred to.Owing to cancerous cell is in forming process, the cancerous cell of propagation needs to consume the substantial amounts of nutrient of human body
Matter, destroys the immunity of human body, resistance, destroys the function of place internal organs organ, make yin-Yang disequilibrium, cause internal organs
Nonfunction, thus causing death.Treatment currently for cancer does not also have the medicine of what specially good effect, and doctor trained in Western medicine is usually and uses
Operative treatment, radiotherapy, chemotherapy, but operative treatment is not often clean because extracing, and easily causes cancerous cell diffusion or turns
Moving, the toxic and side effects of radiation and chemotherapy is big, makes people the most painful, often can adhere to, and midway is discarded, and secondly treatment cost is held high
Expensive, typically other can not bear.A lot of people expected treating, because the traditional Chinese medical science goes up in China by the method for Chinese medicine later
The history of thousand, among the people have many ancestors to stay close side, proved recipe, but due to for many years to the research of motherland Traditional Chinese Medicine not,
Much there are the close side of Chinese herbal medicine of good curative effect, proved recipe are not handed down and are not developed human body diseases, do not play
Traditional Chinese Medicine Chinese medicine is about close side, the effect of proved recipe, although thinks use, but cannot find about close side, the inheritance people of proved recipe or phase
The technology contents closed, faces lost danger, is unfortunately really.
Summary of the invention
In order to overcome the drawbacks described above of existing treatment cancer, the present invention provides a kind of and treats in bladder cancer and carcinoma of prostate
Herbal-composition, in order to alleviate the misery of cancer patient, reduces treatment cost, improves therapeutic effect.
The present inventor is eponym's crossing doctor, the most 74 years old, practised medicine for more than 60 years, according to hereditary recipe, adds this
The research for many years of a person of good sense and experience of practising medicine, sum up a kind of herbal composite treating bladder cancer and carcinoma of prostate, through circumference
Crowd in dozens of kilometres uses, it was demonstrated that good effect, and smelting is faster, and price is low, deeply by the favorable comment of people, determines to announce its prescription
In generation, to inherit and to develop the fine tradition of motherland's Chinese medical culture, benefit the whole mankind.
Cure the disease " general rule the most bitterly, pain the most obstructed " and the principle of " gas row then blood, the stagnation of QI then blood stasis " according to the traditional Chinese medical science, this
Bright selection has and has removing toxic substances and promoting subsidence of swelling pain relieving, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, dampness removing toxin expelling and strengthening vital QI to eliminate pathogenic factors, enhancing human body immunity merit
The Chinese herbal medicine of energy is raw material, uses the manufacture method of Chinese medicine to make decoction, pill or powder, adheres to taking orally the most in right amount,
To when alleviating to the state of an illness or fully recover.
The consumption of medicine each component of the present invention all has preferable curative effect in the range of following weight parts:
Purplevine 30~60 parts, Pedicellus et Pericarpium Trapae 20~40 parts, Rhizoma Paridis 20~40 parts, Rhizoma Arisaematis 15~30 parts, Hirudo 15~30 parts,
Crow egg-shaped thing 50~100 parts, Bufo siccus 30~60 parts, Pseudobulbus cremastrae seu pleiones 30~60 parts, Scolopendra 10~20 parts, Squama Manis 20~40 parts, Scorpio 20
~40 parts, Herba Hedyotidis Diffusae 20~40 parts, Herba Scutellariae Barbatae 20~40 parts, Semen Coicis 20~40 parts, Radix Ginseng Rubra 35~70 parts, Carapax Trionycis 20~40
Part, Thallus Laminariae (Thallus Eckloniae) 15~30 parts, Sargassum 15~30 parts, Aloe 35~70 parts, SHANLING 20~40 parts, Rhizoma Curcumae 20~40 parts, Radix Curcumae 20~
40 parts, the Radix Astragali 30~60 parts, Ganoderma 30~60 parts, Herba Solani Lyrati 20~40 parts, Radix Clematidis 10~20 parts, Radix Salviae Miltiorrhizae 30~60 parts, Folium Artemisiae Argyi 20
~40 parts, Germinatus Phragmitis 25~50 parts, Polyporus 20~40 parts, Spica Prunellae 20~40 parts, Herba Dianthi 25~50 parts, Herba Salviae Chinensis 20~40 parts,
Rhizoma Corydalis 25~50 parts, common fig leaf juice 30~60 parts, eupolyphoge sinensis 20~40 parts.
The preferably weight portion of medicine each component consumption is: Purplevine 45 parts, 30 parts of Pedicellus et Pericarpium Trapae, Rhizoma Paridis 30 parts, raw south
25 parts of star, Hirudo 25 parts, 75 parts of crow egg-shaped thing, Bufo siccus 45 parts, Pseudobulbus cremastrae seu pleiones 45 parts, Squama Manis 30 parts, Scorpio 30 parts, Scolopendra 15 parts, in vain
Serpentis SHECAO 30 parts, Herba Scutellariae Barbatae 30 parts, Semen Coicis 30 parts, Radix Ginseng Rubra 50 parts, Carapax Trionycis 30 parts, Thallus Laminariae (Thallus Eckloniae) 23 parts, Sargassum 23 parts, Aloe 50
Part, SHANLING 30 parts, Rhizoma Curcumae 30 parts, Radix Curcumae 30 parts, the Radix Astragali 45 parts, Ganoderma 45 parts, Herba Solani Lyrati 30 parts, Radix Clematidis 15 parts, Radix Salviae Miltiorrhizae 45 parts,
Folium Artemisiae Argyi 30 parts, Germinatus Phragmitis 35 parts, Polyporus 30 parts, Spica Prunellae 30 parts, Herba Dianthi 30 parts, Herba Salviae Chinensis 30 parts, Rhizoma Corydalis 35 parts, common fig leaf juice 45
Part, eupolyphoge sinensis 30 parts.
The preparation method of the Chinese herbal medicine composition of medicine for the treatment of bladder cancer of the present invention and carcinoma of prostate is: the present invention uses
The manufacture method of Chinese medicine can be made into decoction, pill or powder, and the method wherein making pill comprises the steps:
1. get the raw materials ready: get all each herbal raw material ready by above-mentioned prescription;
2. cleaning-drying: each raw material is cleaned up, and dries;
3. pulverize: pulverize cleaning each crude drug after drying respectively or grind, fineness 50~150 mesh;4. make adjuvant: use face
Powder adds appropriate drinkable water, heats off the pot after boiling and stir into pasty state in pot, stand-by;
5. molding: in pasty dough, mixes the powder of each crude drug, is sufficiently stirred for, and is in harmonious proportion uniformly, and humidity is can agglomerating be
Standard, by hand or comminutor, makes the pill that weight is 0.4g;
6. packaging warehouse-in: the wet pill of system is dried or dries, through checking, sterilize, pack warehouse-in to be finished product.
The using method of medicine of the present invention: the treatment of patient is divided into three phases according to the course of disease:
First stage is the stage being in a bad way, and the dosage of every day is 24~30g, send down with boiled water in three times, the most every time
Take 20~25 pills;Within 10 days, be a course for the treatment of, general 3~6 the course for the treatment of symptom substantially eliminate, enter second stage afterwards,
In second stage, dose is halved, i.e. take 12~15g or 10~13 balls every day, in order to lasting effects, carry out simultaneously
Follow the tracks of and observe, typically through 5~10 courses for the treatment of until symptom all eliminates, through examination in hospital, regard as thorough rehabilitation, after rehabilitation be
Three phases,
In the phase III, every day, dosage was that 4g divides and sooner or later respectively takes 2g, the most each 5 balls, in order to promote the immunologic function of body,
To prevent recurrence.In the convalescent phase III, eat fresh fruit, such as uncooked garlic, fresh date, Semen Juglandis, Fructus Pruni salicinae, peace more
Really, in order to promote the performance of cancer therapy drug.
Medicine of the present invention has a removing toxic substances and promoting subsidence of swelling pain relieving, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, dampness removing toxin expelling, auxiliary the most eliminating evil, strengthens machine
The effect of body immunity function, compared with present curing cancer drug, the present invention has following prominent feature with the most progressive:
1. the raw material of the present invention is all Chinese herbal medicine, and composition is many, and the proportioning of each medicine is unique suitably, makes each taste Chinese herbal medicine energy phase interworking
Closing and coordinate, drug effect is given full play to, and patient's scope that therefore it adapts to is wide, and kinds cancer has good curative effect, especially
The brain cancer, hepatocarcinoma, pulmonary carcinoma and gastric cancer effect are become apparent from;In formula, wherein select Germinatus Phragmitis, Pseudobulbus cremastrae seu pleiones, Rhizoma Paridis, for solving
All poison;Selecting Scolopendra, Scorpio is removing toxic substances and promoting subsidence of swelling eliminating stagnation;Selecting Rhizoma Arisaematis, Thallus Laminariae (Thallus Eckloniae), Sargassum is antiinflammatory, hard masses softening and resolving;Select Hirudo, SHANLING,
Rhizoma Curcumae, eupolyphoge sinensis are removing blood stasis, removing blood stasis;Selecting Herba Solani Lyrati, Radix Salviae Miltiorrhizae is blood-cleaning detoxifying;Bufo siccus, common fig leaf juice is selected to be counteracting toxic substances, draw out pus by applying a plaster to the affected part;Select Radix Curcumae,
Spica Prunellae be circulation of qi promoting, resolving depression, dissipate strongly fragrant;Selecting Herba Salviae Chinensis, Squama Manis, Radix Clematidis, Purplevine is dredging collateral detumescence;Selecting Folium Artemisiae Argyi is all warps, wind sheltering
Cold, turn respectful uncommon gas is warm, helps Rhizoma Corydalis promoting flow of QI and blood pain relieving;Select Aloe, to assist Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Semen Coicis, Qu
Meccah strong dampness removing functions of expelling toxin, because the property of medicine of above medicine is fierce, in case injuring internal organs, therefore the in addition Radix Astragali, Radix Ginseng Rubra, Ganoderma, Trionyx sinensis Wiegmann
First nourishing YIN QI invigorating, the immunologic function of enhancement body, protect internal organs.Kinds cancer can be controlled because of medicine of the present invention and curative effect is fast, effect
Good, short-term can effect a radical cure, the recurrence after healing can be avoided.Medicine preparation method the most of the present invention is simple, treats easy to operate, is not required to refer to doctor in hospital
Lead down, take medicine treatment at home, no pain in therapeutic process, do not bother, therefore medical expense is low, and general patient can bear.
3. treating the statistics of 200 examples with medicine of the present invention through inventor for many years, be effectively 100%, cure rate is 87%, its
In, early metaphase cancer cure rate more than 90%, terminal cancer can be survived 5-10.4. points for attention: 1. patient is at therapeutic process
In, the most excited, the most worried, keep mental balance, the most overworked;2. ban on opium-smoking and the opium trade, prohibit against alcoholic drinks, prohibit and eat Semen Arecae
With pickle vegetable, eat fresh vegetables, fruit more;3. prohibit and have sexual intercourse.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described: but the present invention not only limits to following example.
Embodiment 1: the preparation method of the Chinese herbal medicine composition of medicine for the treatment of bladder cancer and carcinoma of prostate is: it includes walking as follows
Suddenly (pill):
1, get the raw materials ready: get all the crude drug ready by following weight portion: Purplevine 30 parts, 20 parts of Pedicellus et Pericarpium Trapae, Rhizoma Paridis 20 parts, Rhizoma Arisaematis 15
Part, Hirudo 15 parts, 50 parts of crow egg-shaped thing, Bufo siccus 30 parts, Pseudobulbus cremastrae seu pleiones 30 parts, Scolopendra 10 parts, Squama Manis 20 parts, Scorpio 20 parts, Agkistrodon
SHECAO 20 parts, Herba Scutellariae Barbatae 20 parts, Semen Coicis 20 parts, Radix Ginseng Rubra 35 parts, Carapax Trionycis 20 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts, Sargassum 15 parts, Aloe 35 parts, mountain
20 parts of rib, Rhizoma Curcumae 20 parts, Radix Curcumae 20 parts, the Radix Astragali 30 parts, Ganoderma 30 parts, Herba Solani Lyrati 20 parts, Radix Clematidis 10 parts, Radix Salviae Miltiorrhizae 30 parts, Folium Artemisiae Argyi 20
Part, Germinatus Phragmitis 25 parts, Polyporus 20 parts, Spica Prunellae 20 parts, Herba Dianthi 25 parts, Herba Salviae Chinensis 20 parts, Rhizoma Corydalis 25 parts, common fig leaf juice 30 parts, ground
Trionyx sinensis Wiegmann 20 parts;
2. cleaning-drying: each raw material is cleaned up, and dries;
3. pulverize: pulverize cleaning each crude drug after drying respectively or grind, fineness 50~150 mesh;4. make adjuvant: use face
Powder adds appropriate drinkable water, heats off the pot after boiling and stir into pasty state in pot, stand-by;
5. molding: in pasty dough, mixes the powder of each crude drug, is sufficiently stirred for, and is in harmonious proportion uniformly, and humidity is can agglomerating be
Standard, by hand or comminutor, makes the pill that weight is 0.4g;
6. packaging warehouse-in: the wet pill of system is dried or dries, through checking, sterilize, pack warehouse-in to be finished product.
The preparation method of the Chinese herbal medicine composition of medicine that example 2 treats bladder cancer and carcinoma of prostate is: it comprises the steps
(pill):
A, get all the crude drug of following weight portion ready: Purplevine 60 parts, 40 parts of Pedicellus et Pericarpium Trapae, Rhizoma Paridis 40 parts, Rhizoma Arisaematis 30 parts, Hirudo
30 parts, 100 parts of crow egg-shaped thing, Bufo siccus 60 parts, Pseudobulbus cremastrae seu pleiones 60 parts, Scolopendra 20 parts, Squama Manis 40 parts, Scorpio 40 parts, Herba Hedyotidis Diffusae 40
Part, Herba Scutellariae Barbatae 40 parts, Semen Coicis 40 parts, Radix Ginseng Rubra 70 parts, Carapax Trionycis 40 parts, Thallus Laminariae (Thallus Eckloniae) 30 parts, Sargassum 30 parts, Aloe 70 parts, SHANLING 40 parts,
Rhizoma Curcumae 40 parts, Radix Curcumae 40 parts, the Radix Astragali 60 parts, Ganoderma 60 parts, Herba Solani Lyrati 40 parts, Radix Clematidis 20 parts, Radix Salviae Miltiorrhizae 60 parts, Folium Artemisiae Argyi 40 parts, Germinatus Phragmitis
50 parts, Polyporus 40 parts, Spica Prunellae 40 parts, Herba Dianthi 50 parts, Herba Salviae Chinensis 40 parts, Rhizoma Corydalis 50 parts, common fig leaf juice 60 parts, eupolyphoge sinensis 40 parts;
B, all above herbal raw material is cleaned, dried, wear into fine powder with flour mill, then with appropriate flour and appropriate
Water is cooked into pasty state in pot, and medicated powder end is placed on uniform mixing in pot, and humidity is as the criterion can pinch into stone roller, makes every weight 0.4g's
A ball, dry treatment bladder cancer and the Chinese herbal medicine composition of medicine pill of carcinoma of prostate.Described can also add when mixing and stirring suitable
Amount Mel make with making ball machine a ball of every weight 0.4g, paper using or bottle packaging treat bladder cancer and the medium-height grass of carcinoma of prostate
Medicine composition of medicine pill, patient's method as described in doctor or description is taken and just may be used.
Several model case be described below:
1. easily certain, man, 58 years old, in June, 2014, through Changde City one, examination in hospital was diagnosed as bladder cancer, because not being in hospital without money,
Taking this herbal composite ball after going home often to eat and 10 set a date and take breakfast, lunch and dinner, 20 days symptoms of taking medicine have taken a turn for the better, and take medicine two continuously
Individual month, symptom substantially eliminated, and hereafter dose halves medication 10 months, thorough rehabilitation, prevent from recurring often meal 4 grams of morning and evenings take 1 meal,
Time is 10 months, is now still still living and in good health.
2. Chen, man, 55 years old, in JIUYUE, 2014, through moral mountain, Changde City, examination in hospital was diagnosed as carcinoma of prostate, because of without Qian Zhi
Disease, treatment of going home, take this Chinese herbal medicine ball and often eat 4 grams, every day breakfast, lunch and dinner, 10 days symptoms of taking medicine are clearly better, and pulmonary's alleviation of pain is light,
Continuing to take medicine 2 months, symptom thoroughly eliminates, and later with low dose of every day 6 grams, takes in three times, drug withdrawal after serveing on 10 months, existing
There are 10 years the most healthy.
Claims (4)
1. treat a herbal composite for bladder cancer and carcinoma of prostate, it is characterized in that: medicine of the present invention is by following weight parts
Raw material composition:
Purplevine 30~60 parts, Pedicellus et Pericarpium Trapae 20~40 parts, Rhizoma Paridis 20~40 parts, Rhizoma Arisaematis 15~30 parts, Hirudo 15~30 parts,
Crow egg-shaped thing 50~100 parts, Bufo siccus 30~60 parts, Pseudobulbus cremastrae seu pleiones 30~60 parts, Scolopendra 10~20 parts, Squama Manis 20~40 parts, Scorpio 20
~40 parts, Herba Hedyotidis Diffusae 20~40 parts, Herba Scutellariae Barbatae 20~40 parts, Semen Coicis 20~40 parts, Radix Ginseng Rubra 35~70 parts, Carapax Trionycis 20~40
Part, Thallus Laminariae (Thallus Eckloniae) 15~30 parts, Sargassum 15~30 parts, Aloe 35~70 parts, SHANLING 20~40 parts, Rhizoma Curcumae 20~40 parts, Radix Curcumae 20~
40 parts, the Radix Astragali 30~60 parts, Ganoderma 30~60 parts, Herba Solani Lyrati 20~40 parts, Radix Clematidis 10~20 parts, Radix Salviae Miltiorrhizae 30~60 parts, Folium Artemisiae Argyi 20
~40 parts, Germinatus Phragmitis 25~50 parts, Polyporus 20~40 parts, Spica Prunellae 20~40 parts, Herba Dianthi 25~50 parts, Herba Salviae Chinensis 20~40 parts,
Rhizoma Corydalis 25~50 parts, common fig leaf juice 30~60 parts, eupolyphoge sinensis 20~40 parts.
2., according to treating bladder cancer and the herbal composite of carcinoma of prostate described in claims 1, it is characterized in that: medicine of the present invention
Thing also can be made up of the raw material of following weight parts: Purplevine 45 parts, 30 parts of Pedicellus et Pericarpium Trapae, Rhizoma Paridis 30 parts, Rhizoma Arisaematis 25 parts, Hirudo
25 parts, 75 parts of crow egg-shaped thing, Bufo siccus 45 parts, Pseudobulbus cremastrae seu pleiones 45 parts, Squama Manis 30 parts, Scorpio 30 parts, Scolopendra 15 parts, Herba Hedyotidis Diffusae 30
Part, Herba Scutellariae Barbatae 30 parts, Semen Coicis 30 parts, Radix Ginseng Rubra 50 parts, Carapax Trionycis 30 parts, Thallus Laminariae (Thallus Eckloniae) 23 parts, Sargassum 23 parts, Aloe 50 parts, SHANLING 30 parts,
Rhizoma Curcumae 30 parts, Radix Curcumae 30 parts, the Radix Astragali 45 parts, Ganoderma 45 parts, Herba Solani Lyrati 30 parts, Radix Clematidis 15 parts, Radix Salviae Miltiorrhizae 45 parts, Folium Artemisiae Argyi 30 parts, Germinatus Phragmitis
35 parts, Polyporus 30 parts, Spica Prunellae 30 parts, Herba Dianthi 30 parts, Herba Salviae Chinensis 30 parts, Rhizoma Corydalis 35 parts, common fig leaf juice 45 parts, eupolyphoge sinensis 30 parts.
3. described in claims 1 or 2, state the preparation method of the Chinese herbal medicine composition of medicine for the treatment of bladder cancer and carcinoma of prostate
It is to it is characterized in that: the method comprises the steps (pill):
. get the raw materials ready: get all each herbal raw material ready by prescription;
. cleaning-drying: each raw material is cleaned up, and dries;
. pulverize: pulverize cleaning each crude drug after drying respectively or grind, fineness 50~150 mesh;
. make adjuvant: add appropriate drinkable water with flour, heat in pot off the pot after boiling and stir into pasty state, stand-by;
. molding: in pasty dough, mix the powder of each crude drug, be sufficiently stirred for, be in harmonious proportion uniformly, humidity is can agglomerating be
Standard, by hand or comminutor, makes the pill that weight is 0.4g;
. packaging warehouse-in: the wet pill of system is dried or dries, through checking, sterilize, pack warehouse-in to be finished product.
4. according to the preparation method of the Chinese herbal medicine composition of medicine treating bladder cancer and carcinoma of prostate described in claims 3 it is, its
Feature is: when mixing and stirring of described forming step, can add proper honey with making ball machine and make every ball weighing 0.4g, paper using
Or bottle packaging treatment bladder cancer and the Chinese herbal medicine composition of medicine pill of carcinoma of prostate, patient as doctor or description described in just
Canonical is with just may be used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610691275.3A CN106177772A (en) | 2016-08-21 | 2016-08-21 | A kind of herbal composite treating bladder cancer and carcinoma of prostate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610691275.3A CN106177772A (en) | 2016-08-21 | 2016-08-21 | A kind of herbal composite treating bladder cancer and carcinoma of prostate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106177772A true CN106177772A (en) | 2016-12-07 |
Family
ID=57522083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610691275.3A Pending CN106177772A (en) | 2016-08-21 | 2016-08-21 | A kind of herbal composite treating bladder cancer and carcinoma of prostate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106177772A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113101323A (en) * | 2021-04-06 | 2021-07-13 | 叶有焕 | Chinese herbal medicine composition for treating prostate cancer and preparation thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198226A (en) * | 2011-06-09 | 2011-09-28 | 彭道生 | Chinese herbal medicine composition for treating cancer |
CN103768543A (en) * | 2014-03-03 | 2014-05-07 | 陈海林 | Medicament for treating bladder cancer |
CN104173950A (en) * | 2014-09-15 | 2014-12-03 | 程惠华 | Chinese herbal medicine composition for treating prostatic cancer |
-
2016
- 2016-08-21 CN CN201610691275.3A patent/CN106177772A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198226A (en) * | 2011-06-09 | 2011-09-28 | 彭道生 | Chinese herbal medicine composition for treating cancer |
CN103768543A (en) * | 2014-03-03 | 2014-05-07 | 陈海林 | Medicament for treating bladder cancer |
CN104173950A (en) * | 2014-09-15 | 2014-12-03 | 程惠华 | Chinese herbal medicine composition for treating prostatic cancer |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113101323A (en) * | 2021-04-06 | 2021-07-13 | 叶有焕 | Chinese herbal medicine composition for treating prostate cancer and preparation thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103055130B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
WO2014139282A1 (en) | Pharmaceutical compositions for treating cancer of genital system and preparation method therefor | |
CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
CN102327544A (en) | Traditional Chinese medicinal composition for treating cancer | |
CN101773637A (en) | Broad-spectrum antiviral nano traditional Chinese medicine and preparation method thereof | |
CN102198226A (en) | Chinese herbal medicine composition for treating cancer | |
CN101229355B (en) | Rheumatism soup | |
CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
CN101057922B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
CN102805844A (en) | Medicine for treating liver cancer | |
CN103055111B (en) | Traditional Chinese medicine composition for treating children's infantile malnutrition and preparation method thereof | |
CN106177772A (en) | A kind of herbal composite treating bladder cancer and carcinoma of prostate | |
CN104383336A (en) | Traditional Chinese medicine preparation for postoperative nursing of kidney stone and preparation method of same | |
CN101543616A (en) | Traditional Chinese medicine composition for preventing and treating tumor and its preparation method | |
CN103417876A (en) | Digestion and detoxification pill and preparing method thereof | |
CN106266190A (en) | A kind of herbal composite treating lymph tumor and preparation method thereof | |
CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
CN103285243B (en) | Granules for treating hyperglycemia | |
CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof | |
CN106728060A (en) | It is a kind of to treat externally applied ointment of rheumatism and preparation method thereof | |
CN105833228A (en) | Drug preparation for reversing gastric cancer drug resistance and application thereof | |
CN104258309A (en) | Traditional Chinese medicine composition for treating cancers | |
CN105311468A (en) | Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161207 |